Get started
JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)

JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)

No trades
See on Supercharts
Overview News
Ideas
Discussions Technicals Seasonals Bonds

DJNJ3 trade ideas

Johnson & Johnson head and shouldersLooks like a right shoulder could be forming, weekly chart offers a nice view and divergence for the H&S pattern. A break to the low through 200SMA on a daily chart could signal a nice short. J&J tasked a Federal Judge to take over the 2400 lawsuits because of the baby powder fiasco so company is still dealing with the fallout. Could be a good trade for next week. Although earnings on Tuesday were positive there was no bullish spike. Have a great Easter weekend!
NYSE:JNJ
by Antonio_trader
JNJ: Stuck in a trading range, buybacks are supporting the stockA weekly chart reveals the long-term trading range in which JNJ has been stuck. This Dow component ran up due to buybacks around the start of this year. But the trend and volume-based indicators show a lack of quiet accumulation by Dark Pools. The stock slid down ahead of its earnings release today and gapped up slightly on the report, but there has been considerable profit-taking today as well. So JNJ remains bound in a narrower range just below the trading range highs, where it could languish for some time.
NYSE:JNJ
by MarthaStokesCMT-TechniTrader
$JNJ - Weekly Outlook Feb 25 - Mar 01$JNJ is in a up trending channel and pushing against the upper trend line of the channel. I am seeing resistance area at 137.80 - 138.30. It bounced off daily support nicely and headed straight up. I feel confident it will hit the first profit target 137.80 early next week. This is where you should be taking profits if you are in JNJ. If JNJ runs next week, second profit target 139.55 is also possible. I got into JNJ when I saw it successfully bounced off support and I will exit my position when it hits 137.80 which could be Monday or Tuesday (unless for any reason market sells off at the start of the week). For a longer-term JNJ perspective, Mar 04 looks to be the date when FDA is expected to give its approval on the JNJ's new depression drug. Once approved, JNJ can see a decent pump. US-China trade news can make it go in either direction. Deadline of Mar 01 is next week. Next week is news critical. Markets will make moves depending on what kind of trade-related news we get. If you would like me to analyse a stock ticker, please feel free to mention in the comments. News article for JNJ's new depression drug: www.businessinsider.com
NYSE:JNJLong
by Blackhole-Trading
JNJ Closed above the 20Week Moving Average bullish RSI-LongJNJ Closed above the 20week moving average, has a bullish RSI divergence above 50 and has a J-hook pattern. Immediate target is 150 area and short to intermediate price target appears to be 162.97-167 within a parallel channel. 02/15/2019, Moody's maintains AAA rating with rising revenue. After many years, TALC issues are baked in. Evidence is earnings jump, buyouts, Apple deals, New Depression drug with major Future cash flows and new revenue streams ahead. Latest market decline had little impact on JNJ. The worst appears behind JNJ with growing revenues.
NYSE:JNJLong
by Deepthoughts